Cardamyst Spray
Product Images NDC 83468-070

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Cardamyst (NDC 83468-070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Milestone Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Car15 0003 01)

Chemical structure diagram of the active ingredient etripamil, showing its molecular arrangement with aromatic rings, nitrile group, and methoxy substituents.*

FDA Label Image

Figure 1 (Car15 0003 02)

A Kaplan-Meier curve chart showing cumulative conversion rate (%) over time (minutes) since administration of Cardamyst nasal spray (etripamil) versus placebo. The chart compares treatment efficacy of Cardamyst and placebo up to 300 minutes with numbers at risk listed at intervals below the x-axis.*

FDA Label Image

Figure 2 (Car15 0003 03)

A forest plot comparing the hazard ratios of Cardamyst (etripamil) nasal spray versus placebo across various subgroups, including geography, sex, age, symptom duration, and concomitant medication use. The plot displays hazard ratios with 95% confidence intervals and indicates whether outcomes favor Cardamyst or placebo.*

FDA Label Image

Figure (Car15 0003 04)

An instructional diagram illustrating the components of a nasal spray device, identifying the 'Tip' at the top and the 'Plunger' at the bottom, relevant for the Cardamyst (etripamil) nasal spray.*

FDA Label Image

Figure (Car15 0003 05)

An instructional diagram labeled Step 1, showing two nasal spray bottles placed inside a cup or holder, indicating the first step in using or preparing the nasal spray product Cardamyst (etripamil).*

FDA Label Image

Figure (Car15 0003 06)

An instructional illustration labeled Step 2 shows a woman with shoulder-length brown hair and closed eyes using a nasal spray. She is seated on a gray chair, holding the spray bottle near her nose with one hand. The image demonstrates the proper method to use the nasal spray device.*

FDA Label Image

Figure (Car15 0003 07)

Illustration showing step 3 of using Cardamyst spray, depicting a person holding the nasal spray close to the nostril with an instruction to "Breathe Normally." The image demonstrates proper nasal administration technique for this prescription drug spray.*

FDA Label Image

Figure (Car15 0003 08)

An instructional illustration showing a person holding a nasal spray device labeled as Step 4. The person is positioning the spray device near one nostril, preparing to use the nasal spray for administration.*

FDA Label Image

Figure (Car15 0003 09)

An instructional illustration labeled Step 5 shows a person holding a nasal spray device just below their nostrils with one hand, inhaling normally through the nose. The image includes an upward arrow indicating the spray direction.*

FDA Label Image

Figure (Car15 0003 10)

Instructional illustration showing 'Step 6' for a nasal spray medication, with text advising not to blow the nose for 10 minutes after administration. The image depicts a seated woman with closed eyes, hands resting on her lap, and a clock icon highlighting the 10-minute duration.*

FDA Label Image

Figure (Car15 0003 11)

Instructional illustration showing a hand discarding a spray device into a waste container, indicating proper disposal of the product device.*

FDA Label Image

Figure (Car15 0003 12)

An instructional diagram labeled Step 7 showing how to hold a nasal spray bottle with the thumb underneath and two fingers on top, indicating the correct grip for administering the spray.*

FDA Label Image

Principal Display Panel – 70 mg Carton Label (Car15 0003 13)

Cardamyst (etripamil) nasal spray packaging label for 70 mg/.2 mL strength. The label indicates two 70 mg nasal spray devices per package, with intranasal use only. It includes dosage instructions, storage conditions, and manufacturer information for Milestone Pharmaceuticals USA, Inc. The label features a barcode and QR code for additional information.*

FDA Label Image

Principal Display Panel – 70 mg Device Label (Car15 0003 14)

Label for Cardamyst nasal spray (etripamil) 70 mg per device. It states the device contains one dose of two sprays, is for intranasal use only, and is labeled Rx Only. Manufactured for Milestone Pharmaceuticals Inc. The label includes an NDC number 83468-070-01 and a barcode.*

FDA Label Image

Principal Display Panel – 70 mg Container Label (Car15 0003 15)

Cardamyst (etripamil) nasal spray label showing 70 mg dose per device with two 70 mg nasal spray devices per package. The label includes dosing instructions, storage temperature (20°C to 25°C), and notes for intranasal use only. Manufactured for Milestone Pharmaceuticals USA, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.